Tutogen Shares To Trade On AMEX
CLIFTON, N.J.--(BUSINESS WIRE)--Aug. 16, 2000--Tutogen Medical Inc. (OTC BB: TTGN), today announced that it has been approved for the listing of its common shares on the American Stock Exchange (AMEX).
Trading is scheduled to begin Thursday, August 17, 2000. The new symbol will be TTG.
Mr. Manfred Krueger, President & CEO, said, "I am very pleased that Tutogen Medical, Inc. will be moving to the American Stock Exchange. With Tutogen's move to an internationally recognized stock exchange the Company's securities will become available to a much larger investment community. Tutogen believes that the association with AMEX will provide a whole range of new exposure opportunities. I would like to thank all of our employees and shareholders for their continued support; the Company and I will not disappoint you."
Tutogen Medical, Inc. utilizes its patented Tutoplast(R) process of tissue preservation and viral inactivation, to manufacture bioimplants for neurosurgical, orthopedic, reconstructive and general surgical indications. The Company's Tutoplast(R) products are distributed worldwide by the Mentor Corporation (MNTR), Sulzer Medica (SM) and IOP, Inc., and through subsidiaries in the U.S. and Germany. |
